A Global CRO Delivering Medicines the World Can Trust

At Ergomed, patient-centricity is more than a strategy—it’s the foundation of who we are. Inspired by our founder, Dr. Miroslav Reljanović, a board-certified neurologist and dedicated medical doctor, we are driven by the belief that clinical research has the power to transform lives.

Dr. Reljanović’s vision continues to shape our approach to clinical development, embedding care, compassion, and scientific integrity into every study we support. This legacy is reflected in our deep commitment to the patient experience, hands-on site support, and our unique medic-to-medic engagement model that empowers principal investigators and enhances trial success at the site level.

Since our founding, Ergomed has been a trusted partner to the pharmaceutical and biotech industries, delivering expert support across the full drug development spectrum—from proof-of-concept through Phase I–IV and post-marketing studies. With over 600 clinical trials successfully managed, our track record reflects deep operational strength and scientific insight.

We invest significant resources—including patient engagement strategies, clinician collaboration, and real-time data intelligence—to inform protocol design and drive trial execution. With global scalability and integrated regulatory expertise, Ergomed accelerates time to market with confidence and precision. Our legacy of co-development partnerships reinforces our enduring commitment to sponsor success.

Ergomed is a globally recognized Contract Research Organization (CRO) delivering high-performance clinical research solutions for pharmaceutical and biotechnology companies. With a global footprint spanning North America, Europe, and Asia, we offer scalable support and local insight across every phase of clinical development.

Our extensive team of MDs, PhDs, and industry specialists applies deep scientific expertise to drive success from trial planning through execution. With U.S. hubs in Boston and Raleigh, and regional operations across Western, Central, and Eastern Europe as well as East and South Asia, we provide the global reach and operational flexibility today’s complex trials demand.

Ergomed’s proven experience in oncology, rare disease, and high-complexity studies helps sponsors accelerate development, improve the patient experience, and bring life-changing therapies to market—swiftly and efficiently.